ReShape Lifesciences Inc (RSLS) — Cash Flow-to-Debt Ratio
ReShape Lifesciences Inc (RSLS) has a Cash Flow-to-Debt Ratio of -1.40x as of June 2025, meaning its operating cash flow of $-4.49 Million could theoretically repay -1% of its total liabilities ($3.20 Million) in one year. See how liquid is ReShape Lifesciences Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ReShape Lifesciences Inc Cash Flow-to-Debt Ratio (2005–2024)
Historical debt coverage capacity for ReShape Lifesciences Inc across 20 annual periods. Also explore how fast is ReShape Lifesciences Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ReShape Lifesciences Inc (2005–2024)
Year-by-year debt coverage analysis for ReShape Lifesciences Inc. For market capitalisation and broader financial context, see how much is ReShape Lifesciences Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.88x | $-4.43 Million | $5.05 Million | ▲ +79.3% |
| 2023 | -4.24x | $-16.96 Million | $4.00 Million | ▼ -44.8% |
| 2022 | -2.93x | $-21.90 Million | $7.48 Million | ▼ -55.9% |
| 2021 | -1.88x | $-15.38 Million | $8.19 Million | ▼ -395.9% |
| 2020 | -0.38x | $-8.55 Million | $22.57 Million | ▲ +58.5% |
| 2019 | -0.91x | $-14.20 Million | $15.55 Million | ▲ +51.5% |
| 2018 | -1.88x | $-27.49 Million | $14.61 Million | ▲ +5.6% |
| 2017 | -1.99x | $-24.59 Million | $12.34 Million | ▲ +60.4% |
| 2016 | -5.04x | $-20.66 Million | $4.10 Million | ▼ -76.3% |
| 2015 | -2.86x | $-22.61 Million | $7.91 Million | ▼ -13.8% |
| 2014 | -2.51x | $-19.38 Million | $7.72 Million | ▼ -59.5% |
| 2013 | -1.57x | $-18.43 Million | $11.71 Million | ▲ +0.4% |
| 2012 | -1.58x | $-22.48 Million | $14.22 Million | ▲ +1.3% |
| 2011 | -1.60x | $-19.94 Million | $12.44 Million | ▼ -5.3% |
| 2010 | -1.52x | $-13.66 Million | $8.98 Million | ▲ +34.4% |
| 2009 | -2.32x | $-24.66 Million | $10.63 Million | ▼ -16.2% |
| 2008 | -2.00x | $-33.67 Million | $16.87 Million | ▼ -17.6% |
| 2007 | -1.70x | $-23.37 Million | $13.77 Million | ▲ +21.7% |
| 2006 | -2.17x | $-16.23 Million | $7.49 Million | ▼ -102.1% |
| 2005 | -1.07x | $-10.28 Million | $9.59 Million | — |